Literature DB >> 9931027

Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species.

B J Brock1, M R Waterman.   

Abstract

Microsomal 17alpha-hydroxylase/17,20-lyase cytochrome P450 (P450c17) catalyzes both the 17alpha-hydroxylase reaction required to produce cortisol, the major glucocorticoid in many animals, and the 17, 20-lyase activity required for the production of androgens in all animals. In rodents such as rat, which utilize corticosterone as the major glucocorticoid, P450c17 is expressed predominantly in the gonads, and is absent in the adrenal. In other species including humans, P450c17 is expressed in both adrenal and gonads and participates in both glucocorticoid and androgen production. Rat and human forms of P450c17 are 69% identical at the amino acid level. Based on the differences in physiological roles between P450c17 in these two species, it could be predicted that major differences would be observed in their hydroxylase activities. Contrary to this hypothesis, using partially purified, recombinant human and rat P450c17, we found that the most significant differences lie in their lyase activities. Lyase activities demonstrate that the rat enzyme favors Delta4 (progesterone) substrates while the human enzyme favors Delta5 (pregnenolone) substrates. This substrate preference is also observed in the ability of steroids to decrease uncoupled H2O2 production and to increase stability during turnover. Cytochrome b5, a microsomal electron-transfer protein, enhances lyase activities of rat and human P450c17. However, the most dramatic stimulatory effect is on the human HO-PROG lyase activity. This enhancement of activities is not associated with electron transfer. These differences in biochemical properties between the two forms of P450c17 indicate that human P450c17 has evolved as an enzyme system that limits androgen production to the gonads where a favorable b5:P450c17 ratio exists. Even though orthologous forms of P450c17 are capable of catalyzing the same enzymatic activities, specific physiological requirements of each species ensure biochemical differences between these enzymes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931027     DOI: 10.1021/bi9821059

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

Review 1.  Circulating androgens in women: exercise-induced changes.

Authors:  Carina Enea; Nathalie Boisseau; Marie Agnès Fargeas-Gluck; Véronique Diaz; Benoit Dugué
Journal:  Sports Med       Date:  2011-01-01       Impact factor: 11.136

2.  Neurosteroid transport by the organic solute transporter OSTα-OSTβ.

Authors:  Fang Fang; Whitney V Christian; Sadie G Gorman; Mei Cui; Jiaoti Huang; Kim Tieu; Nazzareno Ballatori
Journal:  J Neurochem       Date:  2010-08-12       Impact factor: 5.372

3.  Human adrenal cells that express both 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and cytochrome b5 (CYB5A) contribute to adrenal androstenedione production.

Authors:  Yasuhiro Nakamura; Yewei Xing; Xiao-Gang Hui; Yumi Kurotaki; Katsuhiko Ono; Tony Cohen; Hironobu Sasano; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-23       Impact factor: 4.292

Review 4.  Defining adrenarche in the rhesus macaque (Macaca mulatta), a non-human primate model for adrenal androgen secretion.

Authors:  A J Conley; B C Moeller; A D Nguyen; S D Stanley; T M Plant; D H Abbott
Journal:  Mol Cell Endocrinol       Date:  2010-12-22       Impact factor: 4.102

Review 5.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

6.  Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.

Authors:  Ningwu Huang; Vishal Agrawal; Kathleen M Giacomini; Walter L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

7.  Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes.

Authors:  Eric Gonzalez; Kevin M Johnson; Pradeep S Pallan; Thanh T N Phan; Wei Zhang; Li Lei; Zdzislaw Wawrzak; Francis K Yoshimoto; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-12-06       Impact factor: 5.157

8.  Mice lacking β-carotene-15,15'-dioxygenase exhibit reduced serum testosterone, prostatic androgen receptor signaling, and prostatic cellular proliferation.

Authors:  Joshua W Smith; Nikki A Ford; Jennifer M Thomas-Ahner; Nancy E Moran; Eric C Bolton; Matthew A Wallig; Steven K Clinton; John W Erdman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

9.  Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.

Authors:  Juilee Rege; Shigehiro Karashima; Antonio M Lerario; Joshua M Smith; Richard J Auchus; Josephine Z Kasa-Vubu; Hironobu Sasano; Yasuhiro Nakamura; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

10.  Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.

Authors:  Taninee Sahakitrungruang; Ningwu Huang; Meng Kian Tee; Vishal Agrawal; William E Russell; Patricia Crock; Nuala Murphy; Claude J Migeon; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.